Zag Bio

Developer of thymus-targeted medicines for autoimmune disease treatment and prevention

placeCambridge, Massachusetts, United States calendar_todayFounded 2022 language zagbio.com

Social engagement

Social engagement: 2.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

10 investors on record; lead investors include Polaris Partners, T1D Fund.

Investor typeCountShare
Venture capital990%
Other / undisclosed110%

Hiring activity

Hires periodically

4 roles tracked across 3 of the last 12 months

9 Feb 2026 · Director / Senior Director, Clinical Operations · Cambridge

3 Nov 2025 · Chief Medical Officer · Cambridge

Based on job postings tracked across public sources.

Recent activity

11 Jun 2026
Event
Longwood Healthcare Leaders MIT CEO Conference
13 May 2026
Event
UBS Private Biotech Innovation Summit
16 Apr 2026
Event
21st Immunology of Diabetes Society Congress & Australian Islet Study Group Meeting
Coming soon